St Anna Children's Hospital

Recent papers from St Anna Children's Hospital

1. The full spectrum of thyroid late effects following hematopoietic stem cell transplantation in pediatrics: insights from a large multicenter cohortFrontiers in Endocrinology · 2026
2. Clinical risk features and genetic findings in essential thrombocythemia and polycythemia vera of childhood and adolescence: prospective insights from the German MPN Childhood RegistryHaematologica · 2026
3. The role of palliative and supportive care in haematopoietic cell transplantation and cellular therapy. Recommendations from the EBMT practice harmonisation and guidelines committeeBone Marrow Transplantation · 2026
4. Exploring the potential of vamotinib in Ph+ leukemias: is it indeed a 3rd generation tyrosine kinase-inhibitor?Journal of Hematology & Oncology · 2026
5. A European study on blood mutation monitoring in children with BRAFV600E-positive Langerhans Cell HistiocytosisBlood Advances · 2026
6. Genotype–phenotype analysis in 333 individuals with heterozygous variants in NFKB1Journal of Human Immunity · 2026
7. Immunotherapy refractoriness and early post-alloHCT relapse define ultra-high-risk B-ALL after CD19 CAR T-cell therapyBlood Advances · 2026
8. Survival Outcomes with IL-2-Free Dinutuximab Beta Treatment Strategies With or Without 13-cis-Retinoic Acid in Relapsed or Refractory Neuroblastoma: An Exploratory Unanchored, Population-Adjusted Comparison of Two Prospective CohortsBiomedicines · 2026
9. Transverse Myelitis and Guillain–Barré Syndrome in Pediatric Lymphoid Malignancies: An International Retrospective StudyPediatric Blood & Cancer · 2026
10. Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic LeukemiaNew England Journal of Medicine · 2026
11. Parvovirus B19 infections in paediatric sickle cell disease patients: Genotype and hydroxyurea treatment influence disease severityBritish Journal of Haematology · 2026
12. Generation of a human induced pluripotent stem cell panel from a family with a heterozygous RPS19 mutation including healthy wild-type, silent carrier and Diamond-Blackfan anemia individualsStem Cell Research · 2026
13. Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcomeLeukemia · 2026
14. Exploring the association between environmental exposure to phthalates and bisphenol A and changes in reproductive hormones in women: a cross-sectional studyScientific Reports · 2026
15. Characteristics and outcome of T‐cell/histiocyte‐rich large B‐cell lymphoma in childhood and adolescence: An international retrospective analysisBritish Journal of Haematology · 2026
16. Total body irradiation versus chemotherapy before stem cell transplantation in children aged two to four with acute lymphoblastic leukemia—an EBMT pediatric diseases working party studyLeukemia · 2026
17. Mutant TP53 allelic states in human hematopoietic stem and progenitor cellsLeukemia · 2026
18. Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic LeukemiaBlood · 2026
19. Crisis readiness for rare disease populations: learnings and recommendations by the European Reference NetworksThe Lancet Regional Health - Europe · 2026
20. A novel STK4 mutation in two siblings with CD4 lymphopenia, recurrent infections and warts: a case report and review of the literatureJournal of Medical Case Reports · 2026